MedTrace Logo

HCG Levels After Ovulation Triggering as Predictors of ICSI Outcome

NCT05969834 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-08-01

No results posted yet for this study

Summary

This study aimed to assess the correlation between HCG levels after ovulation triggering and ICSI outcomes, affected by HCG formulation and dose

Conditions

Interventions

DRUG

uHCG

Final oocyte maturation will be triggered by IM administration of 10000 IU of uHCG (Choriomon)

DRUG

rHCG

Final oocyte maturation will be triggered by SC administration of 6500 IU of rHCG (Ovitrelle)

DRUG

uHCG and GnRHa

Final oocyte maturation will be triggered by combined SC administration of 0.1 mg of GnRHa (Decapeptyl, Triptorelin) and IM administration of 2500 IU of uHCG (Choriomon)

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Engy Abdallah, MSc · Mansoura University

  • Mohamed S Abdelhafez, MD · Mansoura University

  • Mohamed Elzayat, MD · Royal Center

  • Amoura Abou-ElNaga, MD · Mansoura University

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2022-07-19
Completion
2022-08-07

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05969834 on ClinicalTrials.gov